<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03123497</url>
  </required_header>
  <id_info>
    <org_study_id>49RC17_0011</org_study_id>
    <nct_id>NCT03123497</nct_id>
  </id_info>
  <brief_title>Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)</brief_title>
  <acronym>KIT</acronym>
  <official_title>Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of quality of life of patient with chronic idiopathic thrombocytopenic purpura
      according to the type of treatment
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2017</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>quality of life score according to type of treatment</measure>
    <time_frame>at inclusion visit</time_frame>
    <description>quality of life score according to type of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of hospitalisation and consults per year</measure>
    <time_frame>at inclusion visit</time_frame>
    <description>number of hospitalisation and consults per year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>description of general quality of life</measure>
    <time_frame>at inclusion visit</time_frame>
    <description>use ped'sQL general</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>description of general quality of life</measure>
    <time_frame>at inclusion visit</time_frame>
    <description>use ped'sQL fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>description of awareness of parent and patient about Idiopathic thrombocytopenic purpura</measure>
    <time_frame>at inclusion visit</time_frame>
    <description>use Kid's ITO Tools questionnaire</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">183</enrollment>
  <condition>Idiopathic Thrombocytopenic Purpura</condition>
  <arm_group>
    <arm_group_label>Idiopathic Thrombocytopenic Purpura</arm_group_label>
    <description>completion of questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>completion of questionnaire</intervention_name>
    <description>completion of questionnaire for patient and parent</description>
    <arm_group_label>Idiopathic Thrombocytopenic Purpura</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with idiopathic thombocytopenic purpura, aged between 1 and 17 year
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children with Idiopathic thrombocytopenic purpura

          -  aged between 1 and 17 year

          -  Idiopathic thrombocytopenic purpura persistent at 12 months

          -  obtention of informed consent

        Exclusion Criteria:

          -  Persistant/acute Idiopathic thrombocytopenic purpura

          -  concomittant chronic disease, stabilized or not

          -  Concomittant disease with life expectancy &lt; 1 year

          -  Person who have not belong to a social security scheme

          -  Secondary Idiopathic thrombocytopenic purpura
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle Pellier, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>chu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>marianne roumy</last_name>
    <phone>0241356385</phone>
    <phone_ext>+33</phone_ext>
    <email>marianne.roumy@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Roumy</last_name>
      <phone>0241356385</phone>
      <phone_ext>+33</phone_ext>
      <email>marianne.roumy@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle Pellier, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Idiopathic Thrombocytopenic Purpura</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Purpura</mesh_term>
    <mesh_term>Purpura, Thrombocytopenic</mesh_term>
    <mesh_term>Purpura, Thrombocytopenic, Idiopathic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

